Nivolumab (nivo) in sorafenib (sor)-naive and -experienced pts with advanced hepatocellular carcinoma (HCC): CheckMate 040 study - Crocenzi, T S; Yau, T C; Melero, I (2017)
(suppl; abstr 4013)